Rapid diagnostic tests are not reliable The Serology Task Force of the National Coordination Centre for Testing Capacity – a partnership between RIVM, hospitals and laboratories – has collected research results on rapid diagnostic tests
Rapid and accurate contact tracing required in the coming period Now that the Cabinet is relaxing the measures to combat the novel coronavirus step by step, people will go outside more frequently. The chance of the virus spreading again will then increase.
Clear impact achieved by national measures to combat the COVID-19 epidemic To monitor the effect of the measures against the spread of the novel coronavirus, the time when reported COVID-19 patients became ill was examined.
More reports of adverse effects of implants in 2019 In 2019, the Dutch reporting centre for adverse effects of medical implants (MEBI) received 397 reports of suspected adverse effects. The reports concerned 462 implants.
Excess mortality decreasing, now also in nursing- and care homes The actual number of deaths from the novel coronavirus in the Netherlands is higher than the reported numbers that RIVM publishes daily.
COVID-19 in nursing homes It is estimated that about one-third of nursing homes in the Netherlands have at least one patient with COVID-19.
Excess mortality caused by the novel coronavirus (COVID-19) The actual number of deaths from the novel coronavirus in the Netherlands is higher than the reported numbers published by RIVM.
Regional differences in the coronavirus epidemic There are significant regional differences in the coronavirus epidemic in the Netherlands.
Dutch health similar to health in neighbouring countries The health of the Dutch population is broadly in line with that of our neighbours.
Risk assessment method for gene drives RIVM and partner organisations from England, Germany and Belgium have developed a method to assess the risks of gene drives in laboratories.